Kennedy Capital Management, Inc. I Teos Therapeutics, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 155,435 shares of ITOS stock, worth $1.19 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
155,435
Previous 150,250
3.45%
Holding current value
$1.19 Million
Previous $2.23 Million
28.85%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding ITOS
# of Institutions
163Shares Held
36.7MCall Options Held
1.95MPut Options Held
351K-
Black Rock Inc. New York, NY3.73MShares$28.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.18MShares$24.5 Million0.45% of portfolio
-
Boxer Capital, LLC San Diego, CA2.95MShares$22.6 Million1.6% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$21 Million19.24% of portfolio
-
Tang Capital Management LLC San Diego, CA2.41MShares$18.5 Million2.09% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $273M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...